Summit Therapeutics (NASDAQ:SMMT) shares spiked on Thursday, triggering a trading halt after Bloomberg News reported that ...

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ...

Summit Therapeutics jumps 9% as AZN eyes a potential $15 billion licensing deal for its cancer drug, ivonescimab.

Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best high short interest stocks with huge upside potential. On June 30, ...

Shares of Summit Therapeutics (NASDAQ:SMMT) jumped 5% on Thursday following reports that the company is in advanced ...

Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...

Especially high volume was seen for the $25 strike call option expiring July 18, 2025, with 1,411 contracts trading so far today, representing approximately 141,100 underlying shares of SMMT.

In trading on Tuesday, shares of Summit Therapeutics Inc (Symbol: SMMT) crossed above their 200 day moving average of $20.88, changing hands as high as $21.82 per share. Summit Therapeutics Inc ...

On June 2, the firm reaffirmed its Buy rating and maintained a $44 price target, more than double the current $18.21 share ...

The latest price target for Summit Therapeutics (NASDAQ:SMMT) was reported by UBS on July 1, 2025. The analyst firm set a price target for $30.00 expecting SMMT to rise to within 12 months (a ...